Results 221 to 230 of about 503,928 (378)

A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media tickness in middle-aged women. [PDF]

, 2003
DE MICHELE M, FORTUNATO G, IANNUZZI A, MAZZACCARA, CRISTINA, PANICO, SALVATORE, RUBBA, PAOLO OSVALDO FEDERICO, SACCHETTI L., SALVATORE F, TINTO, NADIA, TRONO D, VITALE DF   +10 more
core  

Hypoxia‐Induced Histone Lactylation Promotes Ferroptosis in Cardiomyocytes via the Wnt/β‐Catenin Pathway

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study investigated the effects of histone lactylation on ferroptosis in hypoxia‐induced cardiomyocytes. A hypoxia model was established in AC16 cells treated with 2‐Deoxy‐D‐glucose (2‐DG, a glucose analogue), ferrostatin‐1 (Fer‐1, a selective ferroptosis inhibitor), lactate (LA), sh‐β‐catenin (shRNA of β‐catenin), or SKL2001 (an agonist ...
Xin‐Hua Zhu, Jing‐Wen Hou, Zhong‐Ying Lv, Ming‐Hui Sun, Xiao‐Yang Zhang, Lei Zhang, Mei Wang   +6 more
wiley   +1 more source

Insulin use promotes pro-inflammatory changes in the transcriptome of atherosclerotic plaques in patients with diabetes mellitus. [PDF]

J Mol Cell Cardiol Plus
Bradford A, Yoshida T, Sukhanov S, Woods FF, Delafontaine P, Bazan HA, Woods TC.   +6 more
europepmc   +1 more source

Impact of Denosumab Adherence on Renal Function and Mortality Rates in Type 2 Diabetes Patients With Osteoporosis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Type 2 diabetes mellitus (T2DM) is associated with an increased risk of osteoporosis and fractures, and denosumab, a non‐kidney‐excreted antiresorptive medication, represents a viable alternative to bisphosphonates for osteoporosis treatment in patients with T2DM. This study aimed to investigate the association among denosumab adherence, renal
Yu‐Chuan Chang, Jian‐Chih Chen, Sung‐Yen Lin, Kun‐Der Lin, Pei‐Shan Ho, Chung‐Hwan Chen, Yin‐Chih Fu, Tien‐Ching Lee   +7 more
wiley   +1 more source

Targeted Sustained-Release Therapy for Vulnerable Atherosclerotic Plaques Using Luteolin-Loaded Nanoparticles. [PDF]

Int J Nanomedicine
Wang S, Shi X, Li X, Liu Y, Wang C, Wu Y, Wang Y, Qian W, Li X, Huang J, Li D, Xu T.   +11 more
europepmc   +1 more source

The prevalence and distribution of the atherosclerotic plaques in the abdominal aorta and its branches

, 2016
Ceren Günenç Beşer, Muşturay Karçaaltıncaba, Hakan Hamdi Çelik, R. Başar   +3 more
openalex   +2 more sources

THE EXPRESSION OF THE PROTEASOME EACH SUBUNIT IN HUMAN ATHEROSCLEROTIC PLAQUE [PDF]

, 2012
Chunling Wang, Wang Mingxiao, Jia Wang, Chunling Wang   +3 more
openalex   +1 more source

Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques.

European Heart Journal-Cardiovascular Imaging, 2016
G. Bala, A. Blykers, C. Xavier, B. Descamps, A. Broisat, C. Ghezzi, D. Fagret, G. Van Camp, V. Caveliers, C. Vanhove, T. Lahoutte, S. Droogmans, B. Cosyns, N. Devoogdt, S. Hernot   +14 more
semanticscholar   +1 more source

TET3‐Mediated m5C Modification of CCAT2 Accelerates Cardiac Microvascular Endothelial Cell Damage in Acute Coronary Syndrome

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Acute coronary syndrome (ACS) is a clinical syndrome involving myocardial ischemia. This study aimed to elucidate the mechanism of TET3 in ACS‐induced CMEC damage, thereby identifying a new target for ACS treatment. The expression of TET3 in ACS patients and healthy subjects was analyzed.
Jun‐Cheng Liu, Wen‐Juan Wang, Ting‐Ting Zhang, Qi‐Chong Yang, Haliminai Dilimulati, Song‐Tao An   +5 more
wiley   +1 more source

Rationale and Design of the PASSIVATE-CAP Trial: The Preventive Intervention Value of Drug-Coated Balloons in Vulnerable Coronary Atherosclerotic Plaques. [PDF]

Clin Cardiol
Chen Z, Zhang J, Zhou M, Liang S, Chen Y, Li C, Wang H, Wei J, Huang B, Wang M, He Y, PASSIVATE‐CAP trial investigator.   +11 more
europepmc   +1 more source